LZCIC(600423)
Search documents
柳化股份:柳化股份2023年第三季度主要经营数据公告
2023-10-27 10:21
股票代码:600423 股票简称:柳化股份 公告编号:2023-018 柳州化工股份有限公司 2023 年第三季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律带责任。 根据有关规定,现将公司 2023 年第三季度主要经营数据披露如下: 一、主要产品产量、销量及收入实现情况 | 主要产品 | 年三季度产量 | 2023 | 2023 年三季度销量 | 2023 | 年三季度销售金额 | | --- | --- | --- | --- | --- | --- | | | | (吨) | (吨) | | (万元) | | 27.5%双氧水 | | 29,557.011 | 27,092.98 | | 3,042.00 | | 50%双氧水 | | 3,555.182 | 2,431.49 | | 530.88 | 二、主要产品价格变动情况(不含税) | 主要产品 | 2023 年三季度 | 与上季度相比 | 与去年同期相比 | | --- | --- | --- | --- | | | 平均售价(元/吨) | 变动比率 ...
柳化股份:柳化股份第六届董事会第十四次会议决议公告
2023-10-27 10:21
股票代码:600423 股票简称:柳化股份 公告编号:2023-019 柳州化工股份有限公司 第六届董事会第十四次会议决议公告 6、以七票赞成、零票反对、零票弃权,审议通过了关于补选审计委员会委员的议案。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 柳州化工股份有限公司(以下简称"公司")第六届董事会第十四次会议通知及材料于 2023 年 10 月 20 日以电子邮件方式发出,会议于 2023 年 10 月 27 日在公司会议室召开,会议应参加表决的董事 7 人,实际表 决的董事 7 人,公司监事及高级管理人员列席了会议,本次会议符合《公司法》和《公司章程》的有关规定。 会议由董事长陆胜云先生主持。 二、董事会会议审议情况 经与会董事审议表决,通过了如下议案: 1、以七票赞成、零票反对、零票弃权,审议通过了公司 2023 年第三季度报告(详见同日披露于上海证券 交易所网站:www.sse.com.cn 及上海证券报的《公司 2023 年第三季度报告》)。 2、以七票赞成、零票反对、零票弃权,审议通过 ...
柳化股份:柳化股份第六届监事会第九次会议决议公告
2023-10-27 10:21
股票代码:600423 股票简称:柳化股份 公告编号:2023-020 柳州化工股份有限公司 第六届监事会第九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 柳州化工股份有限公司第六届监事会第九次会议通知及材料于 2023 年 10 月 20 日以电子邮件方式发 出,会议于 2023 年 10 月 27 日在公司会议室召开,参加本次会议的监事应到 3 名,实到 3 名,部分公司 高级管理人员列席了会议,符合《公司法》和《公司章程》的有关规定。会议由监事会召集人牟创先生 主持。 二、监事会会议审议情况 经出席会议的监事审议表决,通过了如下议案: 1、以三票同意、零票反对、零票弃权,审议通过了《2023 年第三季度报告》(详见同日披露于上 海证券交易所网站:www.sse.com.cn 及上海证券报的《公司 2023 年第三季度报告》)。 监事会对董事会编制的公司 2023 年第三季度报告进行了严格审核,并提出以下书面审核意见: (1)公司 2023 年第三季度报告由董事会组织编制,并已提交 ...
柳化股份:柳化股份独立董事关于公司第六届董事会第十四次会议相关议案的独立意见
2023-10-27 10:21
柳州化工股份有限公司独立董事 关于公司第六届董事会第十四次会议相关议案的 独立意见 根据《中华人民共和国公司法》《上海证券交易所股票上市规则》《上市公司独立董 事管理办法》及《公司章程》等有关法律、法规、规范性文件的相关规定,我们作为柳州 化工股份有限公司(以下简称"公司")的独立董事,本着对公司和全体股东负责的态度,基 于独立判断的立场,在认真审阅公司第六届董事会第十四次会议议案后,就部分事项发表如 下独立意见: 一、关于对司法重整账面记载未申报债权进行账务处理的独立意见 公司应收账款债务人广西林业荔浦纸业有限公司已经法院裁定终结其破产程序,认为再 无其他财产可分配的事实,公司拟对该项应收账款进行核销。我们认为:依据《企业会计准 则》及相关规定,结合本次拟核销的应收账款已全额计提坏账准备,符合公司实际情况,决 策程序符合法律法规,不存在损害公司股东尤其是中小股东利益的情形。我们同意本次资产 核销事项。 独立董事签名:薛有冰 杨毅 吴绿秋 2023 年 10月 27 日 s I 公司按照《重整计划》规定,拟对《重整计划》执行完毕之日起满三年仍未向公司主张 权利或虽主张但经审查不成立的债权进行核销账务处理。我们 ...
柳化股份:柳化股份关于召开2023年第二次临时股东大会的通知
2023-10-27 10:21
证券代码:600423 证券简称:柳化股份 公告编号:2023-022 柳州化工股份有限公司 关于召开 2023 年第二次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、 召开会议的基本情况 (一) 股东大会类型和届次 2023 年第二次临时股东大会 召开的日期时间:2023 年 11 月 15 日 14 点 30 分 召开地点:广西柳州市跃进路 106-8 号汇金国际 26 层公司会议室 1 股东大会召开日期:2023年11月15日 本次股东大会采用的网络投票系统:上海证券交易所股东大会网络投票 系统 (六) 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者 的投票,应按照《上海证券交易所上市公司自律监管指引第 1 号 — 规范运 作》等有关规定执行。 (七) 涉及公开征集股东投票权 无 二、 会议审议事项 本次股东大会审议议案及投票股东类型 | 序 | 议案名称 | 投票股东类型 | | --- | --- | ...
柳化股份:柳化股份关于对相关债权及资产进行核销的公告
2023-10-27 10:21
股票代码:600423 股票简称:柳化股份 公告编号:2023-021 柳州化工股份有限公司 关于对相关债权及资产进行核销的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 柳州化工股份有限公司(以下简称"公司")于 2023 年 10 月 27 日召开第六届董事会第十四次会议 及第六届监事会第九次会议审议通过了三项关于对相关债权及资产进行核销的议案。现将相关情况公告 如下: 1、关于对司法重整账面记载未申报债权进行核销账务处理的事项 2019 年 12 月 13 日,公司收到柳州中院(2018)桂 02 破 2 号之八《民事裁定书》,裁定确认公 司重整计划执行完毕并终结公司重整程序,截至目前公司司法重整计划执行完毕已满三年。根据公司《重 整计划》中"自重整计划执行完毕之日起三年内,账面记载未申报债权之债权人主张债权且经审查依法 成立的,按照上述同类债权的清偿条件受偿。超过三年未主张或虽主张但经审查不成立的,不再清偿" 的约定,公司拟对《重整计划》执行完毕公告之日起满三年仍未向公司主张的债权共计 4507.76 万元进 行 ...
柳化股份:柳化股份关于召开2023年半年度业绩说明会的公告
2023-08-10 09:48
股票代码:600423 股票简称:柳化股份 公告编号:2023-017 重要内容提示: ●会议召开时间:2023 年 8 月 18 日(星期五) 15:00-16:00 ●问题征集方式:投资者可于 2023 年 8 月 11 日(星期五)至 8 月 17 日(星期四)16:00 前登录上证路演中 心网站首页点击"提问预征集"栏目或通过公司邮箱 lhgf@vip.163.com 进行提问。公司将在说明会上对投资 者普遍关心的问题进行回答。 柳州化工股份有限公司(以下简称"公司")已于 2023 年 7 月 28 日在《上海证券报》及上海证券交易所 网站(www.sse.com.cn)披露了公司 2023 年半年度报告及其摘要,为便于广大投资者更全面深入地了解公司 2023 年半年度经营成果、财务状况,公司计划于 2023 年 8 月 18 日 15:00-16:00 召开 2023 年半年度业绩说明 会,就投资者关心的问题进行交流。 一、 说明会类型 本次业绩说明会以网络互动形式召开,公司将针对 2023 年半年度的经营成果及财务指标的具体情况与投 资者进行互动交流和沟通,在信息披露允许的范围内就投资者普遍关心 ...
柳化股份(600423) - 2023 Q2 - 季度财报
2023-07-27 16:00
Financial Performance - The company's operating revenue for the first half of 2023 was ¥56,266,043.18, a decrease of 14.95% compared to ¥66,157,909.10 in the same period last year[19]. - The net profit attributable to shareholders for the first half of 2023 was ¥2,232,306.66, down 78.98% from ¥10,622,208.43 in the previous year[19]. - The basic earnings per share for the first half of 2023 was ¥0.003, a decrease of 76.92% from ¥0.013 in the same period last year[21]. - The weighted average return on net assets decreased by 1.97 percentage points to 0.51% from 2.48% in the previous year[21]. - The operating profit for the first half of 2023 was ¥2,232,306.66, down from ¥10,592,228.06 in the first half of 2022, indicating a significant decline in profitability[89]. - The net profit for the first half of 2023 was also ¥2,232,306.66, compared to ¥10,622,208.43 in the same period of 2022, reflecting a decrease of approximately 79%[89]. Cash Flow and Assets - The net cash flow from operating activities increased by 75.88% to ¥16,934,868.95, compared to ¥9,628,771.61 in the same period last year[22]. - Cash and cash equivalents at the end of the period reached ¥418,755,795.07, accounting for 80.58% of total assets, an increase of 2.49% compared to the previous year[39]. - The total assets at the end of the reporting period were ¥519,708,496.80, an increase of 1.28% from ¥513,141,913.12 at the end of the previous year[20]. - The company's total non-current assets reached ¥73,818,273.10, an increase from ¥57,914,985.73 at the end of 2022, indicating a growth of approximately 27.4%[85]. - The company's cash and cash equivalents were ¥418,755,795.07 as of June 30, 2023, compared to ¥408,580,137.82 at the end of 2022, showing a slight increase[84]. Market Conditions and Challenges - The company faced significant challenges due to oversupply in the hydrogen peroxide industry, leading to a substantial decrease in profitability[21]. - The overall market for hydrogen peroxide remains weak, with an expected continuation of low prices due to excess supply and insufficient demand[29]. - The overall market competition for hydrogen peroxide has intensified due to increased production capacity and low downstream demand[28]. Production and Technical Upgrades - The company completed a technical upgrade of its 20,000 tons/year concentrated hydrogen peroxide production system, significantly reducing steam consumption and improving market competitiveness[32]. - The company plans to expand its hydrogen peroxide production capacity by 60,000 tons/year through technical upgrades[31]. - The company is undertaking a technical upgrade project for its 100,000 tons/year hydrogen peroxide facility, with a total investment of approximately ¥22,870,000, expected to enhance production capacity from 100,000 tons to 160,000 tons annually[42]. Environmental Impact and Compliance - The company’s Luozhai subsidiary has been included in the 2023 Liuzhou Environmental Supervision Key Units List, with major pollutants including wastewater, waste gas, and hazardous waste[52]. - Total emissions during the reporting period were 0.0937 tons of volatile organic compounds, 0.000042 tons of ammonia nitrogen, and 0.0043 tons of chemical oxygen demand[52]. - The subsidiary achieved a 100% operational rate for environmental protection facilities in sync with production equipment, ensuring real-time monitoring of emissions[54]. - The company has implemented energy-saving measures, optimizing hydrogen peroxide production processes and eliminating high-energy-consuming equipment, contributing to effective greenhouse gas emission control[60]. - There were no instances of exceeding emission standards during the reporting period[53]. Shareholder Information - As of the end of the reporting period, the total number of ordinary shareholders was 20,645[74]. - The largest shareholder, LiuZhou YuanTong Investment Development Co., Ltd., holds 201,452,434 shares, representing 25.22% of the total shares[76]. - The second largest shareholder, China Construction Bank, holds 49,256,529 shares, accounting for 6.17%[76]. Related Party Transactions - The company expects to engage in related party transactions amounting to approximately 41 million RMB for the purchase of hydrogen and steam, with actual transactions recorded at 15.8 million RMB[68]. - The company sold 0.4 million RMB worth of hydrogen peroxide to a related party, with actual sales amounting to 98.73 thousand RMB[68]. Financial Stability and Governance - The company operates on a continuous basis with no significant doubts regarding its ability to continue operations for the next 12 months[106]. - The financial statements are prepared in accordance with the accounting standards issued by the Ministry of Finance[107]. - The company has not reported any changes in significant accounting policies or estimates for the current period[173]. Inventory and Receivables Management - Inventory rose by 43.33% to ¥7,094,407.76, mainly due to an increase in spare parts and product stock[39]. - The total accounts receivable at the end of the period amounted to CNY 3,591,088.24, with a bad debt provision of CNY 525,345.47, resulting in a net value of CNY 3,065,742.77[182]. - The provision for bad debts increased from CNY 456,447.90 to CNY 525,345.47 during the reporting period[186].
柳化股份(600423) - 2023 Q1 - 季度财报
2023-04-18 16:00
[Important Notes](index=1&type=section&id=Important%20Notes) This section provides essential declarations from the board and management, along with the audit status of the financial statements [Declaration by Board of Directors, Supervisory Board, and Senior Management](index=1&type=section&id=Declaration%20by%20Board%20of%20Directors%2C%20Supervisory%20Board%2C%20and%20Senior%20Management) The company's board, supervisory board, and senior management declare the quarterly report's content to be true, accurate, and complete, assuming legal responsibility - The company's board of directors, supervisory board, and directors, supervisors, and senior management guarantee the truthfulness, accuracy, and completeness of the quarterly report, free from false records, misleading statements, or major omissions, and assume individual and joint legal responsibility[3](index=3&type=chunk) [Audit Status of Financial Statements](index=1&type=section&id=Audit%20Status%20of%20Financial%20Statements) The financial statements for the first quarter of this reporting period are unaudited - The financial statements for the first quarter are unaudited[3](index=3&type=chunk) [Key Financial Data](index=1&type=section&id=Key%20Financial%20Data) This section presents the company's primary accounting data, financial indicators, non-recurring gains and losses, and explanations for significant changes [Key Accounting Data and Financial Indicators](index=1&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) In Q1 2023, operating revenue decreased by 11.31% year-over-year, and net profit attributable to shareholders decreased by 39.39%, while net cash flow from operating activities increased by 91.81%; total assets at period-end grew by 2.53% from year-end Key Accounting Data and Financial Indicators | Item | Current Reporting Period (Yuan) | Year-over-year Change (%) | | :--- | :--- | :--- | | Operating Revenue | 29,435,798.46 | -11.31 | | Net Profit Attributable to Shareholders of Listed Company | 2,020,023.05 | -39.39 | | Net Cash Flow from Operating Activities | 12,357,605.36 | 91.81 | | Basic Earnings Per Share (Yuan/share) | 0.003 | -25.00 | | Weighted Average Return on Net Assets (%) | 0.46 | Decrease 0.33 percentage points | Key Balance Sheet Data | Item | End of Current Reporting Period (Yuan) | End of Previous Year (Yuan) | Change from Previous Year-end (%) | | :--- | :--- | :--- | :--- | | Total Assets | 526,121,797.03 | 513,141,913.12 | 2.53 | | Total Equity Attributable to Shareholders of Listed Company | 438,240,440.15 | 436,830,628.08 | 0.32 | [Non-Recurring Gains and Losses and Amounts](index=2&type=section&id=Non-Recurring%20Gains%20and%20Losses%20and%20Amounts) Total non-recurring gains and losses for this period amounted to 2,641.38 Yuan, primarily from government subsidies recognized in current profit or loss Non-Recurring Gains and Losses | Item | Current Period Amount (Yuan) | | :--- | :--- | | Government subsidies recognized in current profit or loss | 2,641.38 | | Total | 2,641.38 | [Changes and Reasons for Key Accounting Data and Financial Indicators](index=2&type=section&id=Changes%20and%20Reasons%20for%20Key%20Accounting%20Data%20and%20Financial%20Indicators) Several balance sheet items, including accounts receivable, prepayments, and construction in progress, significantly increased due to higher credit sales, advance payments for purchases/expenses, and technical renovation investments; the decline in profit was mainly due to the sluggish hydrogen peroxide market, which reduced selling prices and compressed profit margins; increased operating cash inflow primarily resulted from the settlement of maturing bank acceptance bills Changes and Reasons for Key Accounting Data and Financial Indicators | Item | Change (%) | Primary Reason | | :--- | :--- | :--- | | Accounts Receivable | 57.86 | Primarily due to increased credit sales in the current period | | Prepayments | 2,033.38 | Primarily due to increased advance payments for purchases | | Other Receivables | 845.56 | Primarily due to increased advance payments for expenses | | Construction in Progress | 206.67 | Primarily due to investment in related technical renovation projects | | Other Non-current Assets | 433.68 | Primarily due to increased advance payments for long-term asset acquisitions | | Contract Liabilities | 225.96 | Primarily due to increased advance receipts from customers for goods | | Operating Profit | -39.39 | Primarily due to the sluggish 27.5% hydrogen peroxide market in the current period, leading to a decrease in selling prices compared to the same period last year, which compressed profit margins | | Net Cash Flow from Operating Activities | 91.81 | Primarily due to an increase in maturing bank acceptance bills settled in the current period compared to the same period last year | [Shareholder Information](index=3&type=section&id=Shareholder%20Information) This section details the total number of common shareholders, preferred shareholders with restored voting rights, and the top ten shareholders' holdings [Total Number of Common Shareholders, Preferred Shareholders with Restored Voting Rights, and Top Ten Shareholders' Holdings](index=3&type=section&id=Total%20Number%20of%20Common%20Shareholders%2C%20Preferred%20Shareholders%20with%20Restored%20Voting%20Rights%2C%20and%20Top%20Ten%20Shareholders%27%20Holdings) As of the end of the reporting period, the company had 20,857 common shareholders, with state-owned legal entities dominating the top ten, and Liuzhou Yuantong Investment Development Co., Ltd. as the largest shareholder with a 25.22% stake; some state-owned legal entity shareholders have related party or concerted action relationships - Total number of common shareholders at the end of the reporting period was **20,857**[9](index=9&type=chunk) Top Ten Shareholders' Holdings | Shareholder Name | Shareholder Nature | Number of Shares Held (shares) | Shareholding Percentage (%) | Share Status | Quantity (shares) | | :--- | :--- | :--- | :--- | :--- | :--- | | Liuzhou Yuantong Investment Development Co., Ltd. | State-owned Legal Entity | 201,452,434 | 25.22 | None | 0 | | China Construction Bank Corporation Guangxi Branch | State-owned Legal Entity | 49,256,529 | 6.17 | Unknown | 0 | | Liuzhou Chemical Industry Group Co., Ltd. | State-owned Legal Entity | 22,826,167 | 2.86 | Pledged | 17,260,000 | | | | | | Frozen | 22,826,167 | - Liuzhou Yuantong Investment Development Co., Ltd. is a wholly-owned subsidiary of Liuzhou State-owned Assets Supervision and Administration Commission and acts in concert with Liuhua Group; China Construction Bank Corporation Guangxi Branch acts in concert with CCB Financial Leasing Co., Ltd[10](index=10&type=chunk) [Other Reminders](index=4&type=section&id=Other%20Reminders) This section addresses any other significant information regarding the company's operating performance during the reporting period that investors should note [Other Important Information Regarding the Company's Operating Performance During the Reporting Period That Investors Should Note](index=4&type=section&id=Other%20Important%20Information%20Regarding%20the%20Company%27s%20Operating%20Performance%20During%20the%20Reporting%20Period%20That%20Investors%20Should%20Note) There is no other important information regarding the company's operating performance during the reporting period that requires special attention from investors - No other important information regarding the company's operating performance during the reporting period requires investor attention[11](index=11&type=chunk) [Quarterly Financial Statements](index=5&type=section&id=Quarterly%20Financial%20Statements) This section presents the company's unaudited quarterly financial statements, including the balance sheet, income statement, and cash flow statement [Type of Audit Opinion](index=5&type=section&id=Type%20of%20Audit%20Opinion) The financial statements for this quarter are unaudited - The financial statements for this quarter are unaudited[12](index=12&type=chunk) [Financial Statements](index=5&type=section&id=Financial%20Statements) This section includes the company's unaudited balance sheet, income statement, and cash flow statement, reflecting its financial position, operating results, and cash flows for Q1 2023 [Balance Sheet](index=5&type=section&id=Balance%20Sheet) As of March 31, 2023, total assets were **526.12 million Yuan**, a 2.53% increase from year-end, with monetary funds being the largest current asset and fixed assets/construction in progress as major non-current assets; total liabilities were **87.88 million Yuan**, and total owner's equity was **438.24 million Yuan** Balance Sheet | Item | March 31, 2023 (Yuan) | December 31, 2022 (Yuan) | | :--- | :--- | :--- | | Monetary Funds | 416,729,471.84 | 408,580,137.82 | | Accounts Receivable | 2,826,744.47 | 1,790,698.53 | | Prepayments | 3,168,143.66 | 148,503.41 | | Construction in Progress | 3,516,124.52 | 1,146,560.73 | | Total Assets | 526,121,797.03 | 513,141,913.12 | | Total Liabilities | 87,881,356.88 | 76,311,285.04 | | Total Owner's Equity | 438,240,440.15 | 436,830,628.08 | [Income Statement](index=7&type=section&id=Income%20Statement) In Q1 2023, the company achieved operating revenue of **29.44 million Yuan**, a 11.31% year-over-year decrease, with operating costs of **28.80 million Yuan**, and net profit of **2.02 million Yuan**, a 39.39% year-over-year decrease, primarily due to the sluggish hydrogen peroxide market Income Statement | Item | Q1 2023 (Yuan) | Q1 2022 (Yuan) | | :--- | :--- | :--- | | Operating Revenue | 29,435,798.46 | 33,189,922.46 | | Operating Cost | 28,795,082.21 | 30,989,546.43 | | Operating Profit | 2,020,023.05 | 3,332,803.57 | | Net Profit | 2,020,023.05 | 3,332,803.57 | | Basic Earnings Per Share (Yuan/share) | 0.003 | 0.004 | [Cash Flow Statement](index=8&type=section&id=Cash%20Flow%20Statement) In Q1 2023, net cash flow from operating activities was **12.36 million Yuan**, a significant 91.81% year-over-year increase, mainly due to increased cash received from sales; net cash outflow from investing activities was **4.25 million Yuan**, primarily for acquiring fixed, intangible, and other long-term assets; period-end cash and cash equivalents totaled **388.59 million Yuan** Cash Flow Statement | Item | Q1 2023 (Yuan) | Q1 2022 (Yuan) | | :--- | :--- | :--- | | Cash received from sales of goods and rendering of services | 26,925,587.87 | 17,448,333.68 | | Net Cash Flow from Operating Activities | 12,357,605.36 | 6,442,575.77 | | Cash paid for acquisition of fixed assets, intangible assets, and other long-term assets | 4,251,462.18 | 723,557.10 | | Net Cash Flow from Investing Activities | -4,251,462.18 | -723,557.10 | | Net Increase in Cash and Cash Equivalents | 8,106,143.18 | 5,719,018.67 | | Cash and Cash Equivalents at End of Period | 388,587,214.99 | 368,027,745.00 | [Adjustments to Financial Statements at the Beginning of the First Year of Application of New Accounting Standards or Interpretations from 2023](index=10&type=section&id=Adjustments%20to%20Financial%20Statements%20at%20the%20Beginning%20of%20the%20First%20Year%20of%20Application%20of%20New%20Accounting%20Standards%20or%20Interpretations%20from%202023) The company did not adjust its opening financial statements for the current reporting period due to the initial application of new accounting standards or interpretations - No adjustments were made to the opening financial statements for the current reporting period due to the initial application of new accounting standards or interpretations[19](index=19&type=chunk)
柳化股份:柳化股份关于召开2022年度业绩说明会的公告
2023-03-22 08:04
股票代码:600423 股票简称:柳化股份 公告编号:2023-012 柳州化工股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ●会议召开时间:2023 年 3 月 30 日(星期四)上午 10:00-11:00 ●会议召开地点:上海证券交易所上证路演中心(网址:http://roadshow.sseinfo.com/) ●会议召开方式:上证路演中心网络文字互动 ●问题征集方式:投资者可于 2023 年 3 月 23 日(星期四)至 3 月 29 日(星期三)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 lhgf@vip.163.com 进行提问。 公司将在说明会上对投资者普遍关心的问题进行回答。 (一) 会议召开时间:2023 年 3 月 30 日上午 10:00-11:00 (二) 会议召开地点:上海证券交易所上证路演中心(http://roadshow.sseinfo.com/) (三) 会议召开方式:上证路演中心网络 ...